
Access TeleCare
Tele-Infectious Disease Opportunities [100% Remote]
South Carolina
Access Physician's is expanding its Tele-Infectious Disease service line!
Goals of our ID Program:
- Diagnose, treat, and manage patients with difficult or complicated bacterial, fungal, viral, and parasitic infections
- Decrease unnecessary transfers and increase census
- Support local physicians to manage a higher complexity of disease
Opportunity Highlights
- 1099 Independent Contractor
- Hours of Operation: Monday - Sunday, 7AM-5PM
- Competitive Compensation with RVU Productivity Incentive
- Dedicated Licensing/Credentialing/Privileging Team
- 100% Remote Work (No In-person Coverage or Travel Required)
Minimum Requirements
- BC Internal Medicine and Infectious Disease
- Completion of Infectious Disease Fellowship
- Minimum 2 years' experience
About Access TeleCare
Access TeleCare is the nation’s largest multi-specialty telemedicine physician group that is focused on high-acuity, high-complexity inpatient care. As a physician lead organization, our clinical AND business philosophy is centered around one thing: clinical excellence. Our clinical workforce provides access to care in 8 core service lines throughout the country, all from their home base or home office. As a group, we have been in operation for nearly two decades, so our platform is very well established, and our success stories go as far back as our date of inception.
Apply today by reaching out to Chelsea Page, Senior Physician Recruiter, at (615) 795-3261 or cpage@accesstelecare.com.
About Access TeleCare
Access TeleCare was founded in 2004 by a group of physicians with a vision to deliver high-quality, high-acuity specialty care at scale through technology. Our mission ever since has been to provide timely access to high-quality specialty care – inpatient and outpatient – to measurably improve patient outcomes and support hospitals’ financial sustainability.
Click here for more details about this position.
Compensation Details
$157-193/hour
Base pay + RVU model, targeted for 75% of MGMA.
Posted January 24, 2025